George P. Patrinos

University of Patras — Greece

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

51h-index15.0kcitations534works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(115), Genomics and Rare Diseases(104), Hemoglobinopathies and Related Disorders(64), BRCA gene mutations in cancer(50), Genetics, Bioinformatics, and Biomedical Research(45)

Publications527 total

Additional file 1 of Strategic insights into pharmacogenomics coverage: a theory-informed SWOT analysis of UAE insurance stakeholders’ perspectives
Figshare·2026Open Access
Additional file 1 of Strategic insights into pharmacogenomics coverage: a theory-informed SWOT analysis of UAE insurance stakeholders’ perspectives
Figshare·2026Open Access
Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study
EClinicalMedicine·2025Open Access
Assessing the views and opinions of psychiatric patients receiving genome-guided treatment within the scope of the PREPARE preemptive pharmacogenomics clinical study
Frontiers in Pharmacology·2025Open Access
Comparative analysis of point-of-care bedside cyp2c19-testing guided anti-platelet therapy versus conventional therapies for cardiovascular diseases: a systematic review and meta-analysis
The Pharmacogenomics Journal·2025
Author Correction: Fine-mapping genomic loci refines bipolar disorder risk genes
UNC Libraries·2025Open Access
Fine-mapping genomic loci refines bipolar disorder risk genes
UNC Libraries·2025Open Access
Author Correction: Fine-mapping genomic loci refines bipolar disorder risk genes
Nature Neuroscience·2025Open Access
Disruptive biosecurity: A new concept for preparedness and response to the emerging total biothreat landscape
Comparative Strategy·2025
A multi-centre observational cohort study on pharmacogenomic predictors of rosuvastatin discontinuation in a multiethnic population
Frontiers in Pharmacology·2025· 1 citedOpen Access
Personal Pharmacogenomics for Patient Safety: Results From a Large Psychiatric Patient Cohort
2025Open Access
Bringing our genomes to medicine – the 2026 human genome meeting
Human Genomics·2025Open Access
Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab Emirates
Clinical and Translational Science·2025Open Access
Clinical implementation of pre-emptive pharmacogenomics in patients with anxiety disorders
Nature Mental Health·2025· 1 cited
BioSTEM: A modern educational tool for research and innovation in the field of molecular biology and personalized medicine
Human Genomics·2025Open Access
Fine-mapping genomic loci refines bipolar disorder risk genes
Nature Neuroscience·2025· 11 citedOpen Access
Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study
Clinical Pharmacology & Therapeutics·2025· 4 citedOpen Access
New Genomics Discoveries Across the Bipolar Disorder Spectrum Implicate Neurobiological and Developmental Pathways
Biological Psychiatry·2025· 3 citedOpen Access
Pharmacogenomic insights into atorvastatin and rosuvastatin adverse effects: a prospective observational study in the UAE’s multiethnic population
Human Genomics·2025· 4 citedOpen Access
Genomics and athletic performance: an emerging discipline that is not yet ready for society
Human Genomics·2025· 1 citedOpen Access
page 1 of 27Next →

Frequent Co-authors

Christina Mitropoulou(9), Joseph Borg(8), D.N. Cooper(7), Konstantinos Mitropoulos(7), Belinda Giardine(6), Ross C. Hardison(6), Θεοδώρα Κάτσιλα(6), Cathy Riemer(5), Webb Miller(5), Henri Wajcman(5), David H.K. Chui(5), Ron HN van Schaik(5), Sjaak Philipsen(4), Alessio Squassina(4), Manoussos N. Papadakis(4), Jian‐Min Chen(3), Philippe Joly(3), Marianthi Georgitsi(3), Peter J. van der Spek(3), Alex E. Felice(3)